Haarmann, A.; Vollmuth, C.; Kollikowski, A.M.; Heuschmann, P.U.; Pham, M.; Stoll, G.; Neugebauer, H.; Schuhmann, M.K.
Vasoactive Soluble Endoglin: A Novel Biomarker Indicative of Reperfusion after Cerebral Large-Vessel Occlusion. Cells 2023, 12, 288.
https://doi.org/10.3390/cells12020288
AMA Style
Haarmann A, Vollmuth C, Kollikowski AM, Heuschmann PU, Pham M, Stoll G, Neugebauer H, Schuhmann MK.
Vasoactive Soluble Endoglin: A Novel Biomarker Indicative of Reperfusion after Cerebral Large-Vessel Occlusion. Cells. 2023; 12(2):288.
https://doi.org/10.3390/cells12020288
Chicago/Turabian Style
Haarmann, Axel, Christoph Vollmuth, Alexander M. Kollikowski, Peter U. Heuschmann, Mirko Pham, Guido Stoll, Hermann Neugebauer, and Michael K. Schuhmann.
2023. "Vasoactive Soluble Endoglin: A Novel Biomarker Indicative of Reperfusion after Cerebral Large-Vessel Occlusion" Cells 12, no. 2: 288.
https://doi.org/10.3390/cells12020288
APA Style
Haarmann, A., Vollmuth, C., Kollikowski, A. M., Heuschmann, P. U., Pham, M., Stoll, G., Neugebauer, H., & Schuhmann, M. K.
(2023). Vasoactive Soluble Endoglin: A Novel Biomarker Indicative of Reperfusion after Cerebral Large-Vessel Occlusion. Cells, 12(2), 288.
https://doi.org/10.3390/cells12020288